Israel Englander Ultragenyx Pharmaceutical Inc. Put Options Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
Put Options
1 transactions
Others Institutions Holding RARE
# of Institutions
362Shares Held
89.2MCall Options Held
3.63MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$158 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$111 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$81.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$77.9 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...